Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Bell

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Alzheimer'S Disease : JAD|December 5, 2014
Adverse vascular risk is related to cognitive decline in older adultsAngela L Jefferson, Timothy J Hohman, Dandan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumorsTimothy A Yap, Laura Vidal, Jan Adam, et al.
Leukemia Research|March 6, 2012
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium studySusan Bell Nyland, Daniel J Krissinger, Michael J Clemente, et al.
The Journal of Climate Change and Health|February 6, 2026
Climate change, poverty, and health: A scoping review of the Canadian contextMariya Bezgrebelna, Emil Aliyev, Yaa S A Amoah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experienceLilyana Angelov, Nancy D Doolittle, Dale F Kraemer, et al.
The Oncologist|March 22, 2015
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumorsChooi Peng Lee, N Jane Taylor, Gerhardt Attard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancerShaguna Seth, Yoshiyuki Matsui, Kathy Fosnaugh, et al.
Frontiers in Oncology|June 1, 2012
Family history of cancer in benign brain tumor subtypes versus gliomasQuinn T Ostrom, Christopher McCulloh, Yanwen Chen, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Alzheimer'S Disease : JAD|December 5, 2014
Adverse vascular risk is related to cognitive decline in older adultsAngela L Jefferson, Timothy J Hohman, Dandan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumorsTimothy A Yap, Laura Vidal, Jan Adam, et al.
Leukemia Research|March 6, 2012
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium studySusan Bell Nyland, Daniel J Krissinger, Michael J Clemente, et al.
The Journal of Climate Change and Health|February 6, 2026
Climate change, poverty, and health: A scoping review of the Canadian contextMariya Bezgrebelna, Emil Aliyev, Yaa S A Amoah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experienceLilyana Angelov, Nancy D Doolittle, Dale F Kraemer, et al.
The Oncologist|March 22, 2015
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumorsChooi Peng Lee, N Jane Taylor, Gerhardt Attard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancerShaguna Seth, Yoshiyuki Matsui, Kathy Fosnaugh, et al.
Frontiers in Oncology|June 1, 2012
Family history of cancer in benign brain tumor subtypes versus gliomasQuinn T Ostrom, Christopher McCulloh, Yanwen Chen, et al.
Pageof 4